Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.

Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.

BACKGROUND: Drug-resistance mutations (DRAM) are frequently selected in patients with virological failure defined as viral load (pVL) above 500 copies/ml (c/mL), but few resistance data are available at low-level viremia (LLV). Our objective was to determine the emergence and evolution of DRAM durin...

Full description

Bibliographic Details
Main Authors: Constance Delaugerre, Sébastien Gallien, Philippe Flandre, Dominique Mathez, Rishma Amarsy, Samuel Ferret, Julie Timsit, Jean-Michel Molina, Pierre de Truchis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3349708?pdf=render

Internet

http://europepmc.org/articles/PMC3349708?pdf=render

Similar Items